LONA (LeonaBio) Forward Dividend Yield %: 0.00% (As of Jul. 06, 2026)


LONA LeonaBio Inc LONA
28 GF Score
Price $8.80
! 2 Warning Signs
View Full Analysis

What is LeonaBio Forward Dividend Yield %?

LeonaBio LONA -0.79% 28 Forward Dividend Yield % is 0.00% as of Jul. 06, 2026. GuruFocus rates LONA with a GF Score™ of 28/100. The stock has 2 warning signs investors should review. Among 147 Biotechnology companies, LeonaBio ranks worse than 680271.43% on this metric.

As of today (2026-07-06), the Forward Annual Dividend Yield of LeonaBio is 0.00%.

As of today (2026-07-06), the Trailing Annual Dividend Yield of LeonaBio is 0.00%.

LONA's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.26
* Ranked among companies with meaningful Forward Dividend Yield % only.

LeonaBio's Dividends per Share for the three months ended in Mar. 2026 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


LeonaBio  (NAS:LONA) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


LeonaBio Forward Dividend Yield % Related Terms


LONA vs ICCC, TELO, PYPD: Forward Dividend Yield % Comparison

For the Biotechnology subindustry, LeonaBio's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LeonaBio Forward Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LeonaBio's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where LeonaBio's Forward Dividend Yield % falls into.


LONA
28GF Score
LeonaBio Inc LONA
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LeonaBio Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
LeonaBio (LONA) has a Forward Dividend Yield % of 0.00% as of Jul. 06, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on LeonaBio and its competitors. According to the industry distribution chart, LeonaBio ranks #999999 out of 147 companies in the Biotechnology industry.
Is LeonaBio's Forward Dividend Yield % too high?
LeonaBio's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, LeonaBio ranks #999999 out of 147 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, LeonaBio has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does LeonaBio's Forward Dividend Yield % compare to ICCC and TELO?
According to the Biotechnology industry distribution chart, LeonaBio ranks #999999 out of 147 companies for Forward Dividend Yield %. This places LeonaBio in the lower half of its industry. The industry median Forward Dividend Yield % is 1.26. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Biotechnology company?
The median Forward Dividend Yield % among Biotechnology companies is 1.26, based on 147 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on LeonaBio and its competitors. For the Biotechnology industry, the median Forward Dividend Yield % is 1.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LeonaBio's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LeonaBio stock overvalued right now?
LeonaBio (LONA) has a current Forward Dividend Yield % of 0.00%. The current Forward Dividend Yield % is 0.00%. LeonaBio's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For LeonaBio (LONA), the current Forward Dividend Yield % is 0.00% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LeonaBio Business Description

Address 18706 North Creek Parkway, Suite 104, Bothell, WA, USA, 98011
LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.
28GF Score

Get the complete analysis for LONA

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.80
Price